Synlogic synlogictx.com


Public list: Smart Money VCs (6328) Synthetic Biology (137) Pharma Startups (4732) Portfolio Company Matchmaking M&A (394)

Synlogic is a biotechnology company focusing on delivering the potential of next generation synthetic biology to patients. Synlogic is pioneering the development of a novel class of living medicines, Synthetic Biotics, based on its proprietary drug discovery and development platform.

Synlogic is a biotechnology company focusing on delivering the potential of next generation synthetic biology to patients. Synlogic is pioneering the development of a novel class of living medicines, Synthetic Biotics, based on its proprietary drug d...Show all

Company (IPO / Went public)

Phone: 617-401-9947

Fax:

200 Sidney Street
Suite 320
Cambridge, 02139
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Synlogic $116.4M May 16, 2017
See all 6 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Synlogic Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Atlas VentureVenture CapitalCambridge, Massachusetts, United StatesSeries C, Series B, Series A
Bill & Melinda Gates FoundationNon-Profit FoundationSeattle, Washington, United StatesSeries A - II
AJU IB InvestmentVenture CapitalSeoul, South KoreaSeries C
AJU IB InvestmentVenture CapitalSeoul, South KoreaSeries C
AJU IB InvestmentVenture CapitalSeoul, South KoreaSeries C
Ally Bridge GroupVenture CapitalCentral, Hong KongSeries C
Ally Bridge GroupVenture CapitalCentral, Hong KongSeries C
Arctic Fund ManagementAsset/Investment ManagementOslo, NorwaySeries C
Arctic Fund ManagementAsset/Investment ManagementOslo, NorwaySeries C
See all 12 investors

Competitors

Company Status Description Investors
See all 6 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Bacteria engineered to reduce hyperphenylalaninemia Sep 08, 2016 Apr 17, 2018 Patent
Bacteria engineered to treat a disease or disorder May 13, 2016 Feb 13, 2018 Patent
Bacteria engineered to treat diseases associated with hyperammonemia May 25, 2016 Jun 27, 2017 Patent
Bacteria engineered to treat diseases associated with hyperammonemia Dec 04, 2015 Nov 08, 2016 Patent
Bacteria engineered to treat diseases associated with hyperammonemia May 18, 2017 Application
See all 13 patents